137 related articles for article (PubMed ID: 10805470)
1. Successful treatment of visceral leishmaniasis in Finnish-type congenital nephrotic syndrome.
Grech V; Vella C; Parascandolo R
Pediatr Nephrol; 2000 May; 14(5):410-1. PubMed ID: 10805470
[TBL] [Abstract][Full Text] [Related]
2. Advances in the treatment of leishmaniasis.
Sundar S; Rai M
Curr Opin Infect Dis; 2002 Dec; 15(6):593-8. PubMed ID: 12821836
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of visceral leishmaniasis in children].
Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
[TBL] [Abstract][Full Text] [Related]
4. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
[TBL] [Abstract][Full Text] [Related]
5. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
Rajaram KG; Sud K; Kohli HS; Gupta KL; Sakhuja V
J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience.
Aronson NE; Wortmann GW; Johnson SC; Jackson JE; Gasser RA; Magill AJ; Endy TP; Coyne PE; Grogl M; Benson PM; Beard JS; Tally JD; Gambel JM; Kreutzer RD; Oster CN
Clin Infect Dis; 1998 Dec; 27(6):1457-64. PubMed ID: 9868660
[TBL] [Abstract][Full Text] [Related]
7. Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature.
Collini P; Premchand N; Lockwood D; Greig J
Ann Trop Med Parasitol; 2009 Jul; 103(5):455-9. PubMed ID: 19583915
[No Abstract] [Full Text] [Related]
8. Intradermal treatment of cutaneous leishmaniasis with two antimonial drugs.
Morsy TA; Essa MH; Aboul Anaan AM; Montasser MF
J Egypt Soc Parasitol; 1988 Jun; 18(1):341-4. PubMed ID: 2836525
[No Abstract] [Full Text] [Related]
9. A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan.
Mueller M; Balasegaram M; Koummuki Y; Ritmeijer K; Santana MR; Davidson R
J Antimicrob Chemother; 2006 Oct; 58(4):811-5. PubMed ID: 16916865
[TBL] [Abstract][Full Text] [Related]
10. Presentation of leishmaniasis (Leishmania infantum) in the skin of a patient with severe atopic dermatitis.
Kerr A; Dawe RS; Nathwani D; Evans AT; Ferguson J
Br J Dermatol; 2009 Jul; 161(1):202-3. PubMed ID: 19438451
[No Abstract] [Full Text] [Related]
11. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
[TBL] [Abstract][Full Text] [Related]
12. [Cutaneous leishmaniasis].
Vion B
Rev Med Suisse Romande; 1989 Jun; 109(6):443-9. PubMed ID: 2547241
[No Abstract] [Full Text] [Related]
13. Oral mucosal leishmaniasis as a presenting feature of HIV infection and its management.
Chaudhry Z; Barrett AW; Corbett E; French PD; Zakrzewska JM
J Oral Pathol Med; 1999 Jan; 28(1):43-6. PubMed ID: 9890457
[TBL] [Abstract][Full Text] [Related]
14. Case 4-2005: sodium stibogluconate for cutaneous leishmaniasis.
Hartzell JD; Aronson N
N Engl J Med; 2005 May; 352(18):1929. PubMed ID: 15872214
[No Abstract] [Full Text] [Related]
15. Sodium stibogluconate.
Shrestha NK
Clin Infect Dis; 2006 Nov; 43(10):1371-2. PubMed ID: 17051510
[No Abstract] [Full Text] [Related]
16. [Visceral leishmaniasis: new drugs].
Minodier P; Robert S; Retornaz K; Garnier JM
Arch Pediatr; 2003 Dec; 10 Suppl 5():550s-556s. PubMed ID: 15022780
[TBL] [Abstract][Full Text] [Related]
17. The Leishmaniasis East Africa Platform (LEAP): strengthening clinical trial capacity in resource-limited countries to deliver new treatments for visceral leishmaniasis.
Wasunna M; Musa A; Hailu A; Khalil EA; Olobo J; Juma R; Wells S; Alvar J; Balasegaram M
Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):321-3. PubMed ID: 27268714
[TBL] [Abstract][Full Text] [Related]
18. Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis.
Roberts WL; Hariprashad J; Rainey PM; Murray HW
Am J Trop Med Hyg; 1996 Oct; 55(4):444-6. PubMed ID: 8916804
[TBL] [Abstract][Full Text] [Related]
19. Leishmaniasis presenting to the otolaryngologist: a rare but important cause of persistent hoarseness.
Santangeli L; McCluney NA; Hathorn I; Shakeel M; Anderson C
J Laryngol Otol; 2009 Oct; 123(10):1181-3. PubMed ID: 19128519
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of infantile visceral leishmaniasis].
Minodier P; Faraut-Gambarelli F; Piarroux R; Gire C; Garnier JM; Dumon H
Arch Pediatr; 1999 Jan; 6(1):59-66. PubMed ID: 9974099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
